This page lists feature articles on COVID-19 relevant to people working at St Vincent's Health Australia.
All articles listed are open access unless stated otherwise.
Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: the RECOVERY-RS Randomized Clinical Trial.
JAMA:2022: January 24 Full text
Use of video technology in end-of-life care for hospitalized patients during the COVID-19 pandemic.
American Journal of Critical Care:2022: February 4 Full text
Use of telemedicine for rheumatology practice in Queensland, Australia: experiences before and during the COVID-19 pandemic. AUS
Internal Medicine Journal:2022: February 3 Full text
Pathophysiology and Long Covid
Clinical outcomes among patients with 1-year survival following intensive care unit treatment for COVID-19.
JAMA:2022: January 24 Full text
A prospective study of the impact of glycaemic status on clinical outcomes and anti-SARS-CoV-2 antibody responses among patients with predominantly non-severe COVID-19.
Diabetes Research and Clinical Practice:2022: February 4 Full text
Effects of exercise rehabilitation in patients with long COVID-19.
European Journal of Preventive Cardiology:2022: January 25 Full text
Hypercoagulopathy as a severe Long-term complication of post SARS-CoV-19 infection.
Human Pathology Reports:2022: February 3 Full text
Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): a national, cross-sectional study.
Lancet Child and Adolescent Health:2022: February 7 Full text
Complications following SARS-CoV-2 infection in Victoria, Australia: a record linkage study. AUS
SSRN:2022: February 3 Full text
Prevalence of select new symptoms and conditions among persons aged younger than 20 years and 20 years or older at 31 to 150 days after testing positive or negative for SARS-CoV-2.
JAMA Network Open:2022: February 4 Full text
Association of SARS-CoV-2 infection with serious maternal morbidity and mortality from obstetric complications.
JAMA: 2022: February 7 Full text
Prevalence of common infectious diseases after COVID-19 vaccination and easing of pandemic restrictions in Israel.
JAMA Network Open:2022: February 1 Full text
Tixagevimab and Cilgavimab (Evusheld) for pre-exposure prophylaxis of COVID-19.
JAMA:2022: January 25 Full text
Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study.
Lancet Respiratory Medicine:2022: January 31 Full text
Persistence of protection against SARS-CoV-2 clinical outcomes up to 9 months since vaccine completion: a retrospective observational analysis in Lombardy, Italy.
Lancet Infectious Diseases:2022: January 27 Full text
COVID-19 and the common cold—preexisting coronavirus antibodies may hinder SARS-CoV-2 immunity.
JAMA:2022: January 26 Full text
Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response.
Cell Host and Microbe:2022: 30(1):83-96 Full text
T-cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals.
Cell:2022: February 3 Full text
Immunology of SARS-CoV-2 infection in children.
Nature Immunology:2022: February 1 Full text
COVID-19 and mental health: Impact on symptom burden in older people living with mental illness in residential aged care. AUS
Australasian Journal on Ageing:2022: February 7 Full text